Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Streptozotocin-induced diabetes mellitus increases the risk for atrial fibrillation

Detalhes bibliográficos
Principais autores:	Ziberna, K, Recalde, A, Carnicer, R, Casadei, B
Formato:	Conference item
Publicado em:	Springer Berlin Heidelberg 2016

Registros relacionados

Inducibility, but not stability, of atrial fibrillation is increased by NOX2 overexpression in mice
por: Mighiu, AS, et al.
Publicado em: (2021)

Role of diabetes mellitus in atrial fibrillation and potential new treatments
por: Ziberna, K
Publicado em: (2020)

154 Myocardial nox2 activity regulates atrial fibrillation susceptibility
por: Mighiu, A, et al.
Publicado em: (2017)

Compromised redox homeostasis, altered nitroso-redox balance and therapeutic possibilities in atrial fibrillation
por: Simon, J, et al.
Publicado em: (2016)

BH4 supplementation as a new treatment for diabetic cardiomyopathy
por: Carnicer, R, et al.
Publicado em: (2019)

Identification of patients with atrial fibrillation: a big data exploratory analysis of the UK Biobank
por: Oster, J, et al.
Publicado em: (2020)

Dapagliflozin and Sirtuin-1 interaction and mechanism for ameliorating atrial fibrillation in a streptozotocin-induced rodent diabetic model
por: Wei-Chieh Lee, et al.
Publicado em: (2024-11-01)

Reduced nitric oxide bioactivity increases platelet activation in mice with streptozotocin-induced diabetes mellitus
por: Schafer, A, et al.
Publicado em: (2003)

Mechanisms of atrial fibrillation
por: Wijesurendra, RS, et al.
Publicado em: (2019)

Catheter ablation of atrial fibrillation in patients with diabetes mellitus
por: Allen Wang, MD, et al.
Publicado em: (2020-08-01)

Stages of development of streptozotocin-induced experimental diabetes mellitus
por: T. M. Boychuk, et al.
Publicado em: (2017-09-01)

Stages of development of streptozotocin-induced experimental diabetes mellitus
por: T. M. Boychuk, et al.
Publicado em: (2017-09-01)

BH4 increases nNOS Activity and preserves left ventricular function in diabetes
por: Carnicer Hijazo, R, et al.
Publicado em: (2021)

Effects of Electrical Remodeling on Atrial Fibrillation in Diabetes Mellitus
por: Ling-ling Qian, et al.
Publicado em: (2023-01-01)

Prognostic significance of diabetes mellitus in patients with atrial fibrillation
por: Andreas S. Papazoglou, et al.
Publicado em: (2021-02-01)

Phenotypes of streptozotocin-induced gestational diabetes mellitus in mice
por: Narumi Takahashi, et al.
Publicado em: (2024-01-01)

Phenotypes of streptozotocin-induced gestational diabetes mellitus in mice.
por: Narumi Takahashi, et al.
Publicado em: (2024-01-01)

Streptozotocin-induced diabetes mellitus affects lysosomal enzymes in rat liver
por: G.B. Peres, et al.
Publicado em: (2014-06-01)

Evaluation of the role of miR-31-dependent reduction in dystrophin and nNOS on atrial-fibrillation-induced electrical remodelling in man
por: Reilly, S, et al.
Publicado em: (2015)

Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus
por: R. Gimenes, et al.
Publicado em: (2018-01-01)

Streptozotocin model of stable diabetes mellitus
por: G. N. Skaletskaya, et al.
Publicado em: (2019-01-01)

The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights
por: Loryn J. Bohne, et al.
Publicado em: (2019-02-01)

How to risk stratify new‐onset atrial fibrillation in patients with hypertension and diabetes mellitus
por: Naoya Kataoka, et al.
Publicado em: (2024-02-01)

ATRIAL FIBRILLATION COMBINED WITH DIABETES MELLITUS. POSSIBILITIES OF USING RIVAROXABAN
por: Alexey D. Ehrlich
Publicado em: (2018-12-01)

Mechanism of and Therapeutic Strategy for Atrial Fibrillation Associated with Diabetes Mellitus
por: Yubi Lin, et al.
Publicado em: (2013-01-01)

The incidence of atrial fibrillation in type 2 diabetes mellitus patients
por: Jandrić-Kočič Marijana
Publicado em: (2020-01-01)

Morphology of bronchial epithelium in rodent streptozotocin-induced diabetes mellitus
por: Oksana Anatolyevna Pivovarova, et al.
Publicado em: (2013-12-01)

Changes in the pharmacokinetics of glibenclamide in rats with streptozotocin-induced diabetes mellitus
por: Yuqing Li, et al.
Publicado em: (2012-04-01)

Seek and ye shall find… subclinical atrial fibrillation in high-risk elderly patients.
por: Wijesurendra, R, et al.
Publicado em: (2017)

Evaluation of plasma homocysteine status in streptozotocin induced-diabetes mellitus in rabbit
por: K Azimzadeh, et al.
Publicado em: (2009-08-01)

Clinical Overview of Obesity and Diabetes Mellitus as Risk Factors for Atrial Fibrillation and Sudden Cardiac Death
por: Edwin A. Homan, et al.
Publicado em: (2019-01-01)

Diabetes Mellitus Is an Independent Risk Factor for a Stiff Left Atrial Physiology After Catheter Ablation for Atrial Fibrillation
por: Moon-Hyun Kim, et al.
Publicado em: (2022-03-01)

Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study
por: JungMin Choi, et al.
Publicado em: (2023-01-01)

Atrial fibrillation: a new facet of diabetes mellitus in the XXI century
por: Andrey Alexeevich Aleksandrov, et al.
Publicado em: (2011-03-01)

Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2
por: Alexander Kogan, et al.
Publicado em: (2023-03-01)

Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
por: Hisao Ogawa, et al.
Publicado em: (2022-03-01)

OSC16: Effects of streptozotocin-induced diabetes mellitus on peri-implantitis
por: ..
Publicado em: (2018-01-01)

Molecular Basis of Atrial Nitroso-Redox Imbalance in Permanent Human Atrial Fibrillation
por: Reilly, S, et al.
Publicado em: (2009)

Atrial appendage closure is associated with increased risk for postoperative atrial fibrillation
por: Jeffrey H. Shuhaiber, et al.
Publicado em: (2024-11-01)

Is increased myocardial oxidative stress an early event in the natural history of atrial fibrillation?
por: Reilly, S, et al.
Publicado em: (2007)